210 modeling-and-simulation-"UNIVERSITY-OF-SOUTHAMPTON" Postdoctoral positions at Nature Careers
Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
—for bacterial control and therapeutic application. Together, we identify functional prophage genes, develop genetic tools, and test engineered phages in infection models. Your tasks Plan and perform in vitro and
-
diverse academic backgrounds to contribute to our projects in areas such as: Network Security, Information Assurance, Model-driven Security, Cloud Computing, Cryptography, Satellite Systems, Vehicular
-
promoters. You will train and evaluate predictive models in model/crop species with different levels of genome complexity. You will work very closely together with your dry-lab colleagues for data processing
-
diverse academic backgrounds to contribute to our projects in areas such as: Network Security, Information Assurance, Model-driven Security, Cloud Computing, Cryptography, Satellite Systems, Vehicular
-
Researcher – Dr Luke Isbel’s Lab (https://researchers.adelaide.edu.au/profile/luke.isbel ) • Focus: Epigenetic regulation of gene expression using stem cell models and functional genomics • Requirements: PhD
-
for pediatric diseases. Our research focuses on how genetic variants contribute to diseases during early development and on developing mechanism-driven therapeutics. While animal models have advanced our
-
optimizing simulation tools such as CalPhad to support experimental findings. Conducting in-depth metallographic analysis and establishing correlations between mechanical properties and microstructural
-
uses a range of approaches, including in vivo and ex vivo mouse models, primary human cell culture, and in vitro organoid cultures. Responsibilities Responsibilities include conceptualizing and
-
to integrate various structural biology data (NMR, SAXS, FRET, EPR) as well as computational models and simulations to create and interpret conformational ensembles of disordered protein regions, with the goal
-
alters immune responses against vaccines using next-generation human tissue and organoid models. Current vaccines against infectious diseases and cancer benefit only a subset of patients, partly due to our